Patients with fibromyalgia appear to have specific gut microbiome alterations that differ from their healthy peers, new research suggests.
In the “first evidence” to show this connection, investigators found that women with fibromyalgia had significant differences in 19 species of gut bacteria compared with healthy controls. They also had higher serum levels of butyrate and lower levels of propionate.
In addition, machine-learning algorithms showed diagnostic prediction accuracy ratings of 87%–88%.
“To the best of our knowledge, this is the first demonstration of gut microbiome alteration in non-visceral pain,” the researchers note.
The findings were published in The Pain Journal (the official publication of the International Association for the Study of Pain.)
Read the full report from Medscape.